| Product Code: ETC7650196 | Publication Date: Sep 2024 | Updated Date: Oct 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Vasudha | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Israel Drug Development Market Overview |
3.1 Israel Country Macro Economic Indicators |
3.2 Israel Drug Development Market Revenues & Volume, 2021 & 2031F |
3.3 Israel Drug Development Market - Industry Life Cycle |
3.4 Israel Drug Development Market - Porter's Five Forces |
3.5 Israel Drug Development Market Revenues & Volume Share, By Mode, 2021 & 2031F |
3.6 Israel Drug Development Market Revenues & Volume Share, By Process Step, 2021 & 2031F |
3.7 Israel Drug Development Market Revenues & Volume Share, By Therapeutic Area, 2021 & 2031F |
4 Israel Drug Development Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing investment in research and development activities in the pharmaceutical industry in Israel |
4.2.2 Growing demand for innovative drugs and therapies in the market |
4.2.3 Favorable government initiatives and policies supporting drug development and commercialization |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for drug approval and market entry |
4.3.2 High costs associated with drug development, clinical trials, and manufacturing processes |
4.3.3 Limited availability of skilled workforce and expertise in certain specialized areas of drug development |
5 Israel Drug Development Market Trends |
6 Israel Drug Development Market, By Types |
6.1 Israel Drug Development Market, By Mode |
6.1.1 Overview and Analysis |
6.1.2 Israel Drug Development Market Revenues & Volume, By Mode, 2021- 2031F |
6.1.3 Israel Drug Development Market Revenues & Volume, By In house, 2021- 2031F |
6.1.4 Israel Drug Development Market Revenues & Volume, By Outsourced, 2021- 2031F |
6.2 Israel Drug Development Market, By Process Step |
6.2.1 Overview and Analysis |
6.2.2 Israel Drug Development Market Revenues & Volume, By Process Research Development, 2021- 2031F |
6.2.3 Israel Drug Development Market Revenues & Volume, By Formulation, 2021- 2031F |
6.2.4 Israel Drug Development Market Revenues & Volume, By Analytical & Stability Studies, 2021- 2031F |
6.2.5 Israel Drug Development Market Revenues & Volume, By DMPK, 2021- 2031F |
6.2.6 Israel Drug Development Market Revenues & Volume, By Safety Assessment (Toxicology), 2021- 2031F |
6.2.7 Israel Drug Development Market Revenues & Volume, By Regulatory Compliance, 2021- 2031F |
6.3 Israel Drug Development Market, By Therapeutic Area |
6.3.1 Overview and Analysis |
6.3.2 Israel Drug Development Market Revenues & Volume, By Oncology, 2021- 2031F |
6.3.3 Israel Drug Development Market Revenues & Volume, By Inflammation & Immunology, 2021- 2031F |
6.3.4 Israel Drug Development Market Revenues & Volume, By Cardiology, 2021- 2031F |
6.3.5 Israel Drug Development Market Revenues & Volume, By Neuroscience, 2021- 2031F |
6.3.6 Israel Drug Development Market Revenues & Volume, By Others, 2021- 2031F |
7 Israel Drug Development Market Import-Export Trade Statistics |
7.1 Israel Drug Development Market Export to Major Countries |
7.2 Israel Drug Development Market Imports from Major Countries |
8 Israel Drug Development Market Key Performance Indicators |
8.1 Percentage increase in the number of patents filed for new drug molecules in Israel |
8.2 Number of collaborations and partnerships between Israeli pharmaceutical companies and global biotech firms |
8.3 Percentage growth in research grants and funding towards drug development projects in Israel |
9 Israel Drug Development Market - Opportunity Assessment |
9.1 Israel Drug Development Market Opportunity Assessment, By Mode, 2021 & 2031F |
9.2 Israel Drug Development Market Opportunity Assessment, By Process Step, 2021 & 2031F |
9.3 Israel Drug Development Market Opportunity Assessment, By Therapeutic Area, 2021 & 2031F |
10 Israel Drug Development Market - Competitive Landscape |
10.1 Israel Drug Development Market Revenue Share, By Companies, 2024 |
10.2 Israel Drug Development Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here